Clinical Trials Browser

Phase NA × peginterferon alfa-2b × Lymphoid × Clear all

NCT00574730 2023-09-14

CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma

Phase NA Completed

Lymphoma, Non-Hodgkin

NCT00724061 2018-12-12

Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL

Phase NA Terminated

7 enrolled 5 charts

DermatologicLymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous